INS and myeloid sarcoma: MS is defined as a group of IR markers, i.e., high blood pressure, impaired glucose metabolism, high serum triglyceride, and low serum High Density Lipoprotein (HDL), which result in triggering resistance to insulin-stimulated glucose uptake [33].